• Coriolis Pharma Expands ATMP Development Facilities contractpharma
    June 22, 2021
    ​Coriolis Pharma, a provider of research and development of for (bio)pharmaceutical drugs, is expanding its advanced therapy medicinal products (ATMP) development facilities under biosafety level S2 (BSL2 / S2).
PharmaSources Customer Service